Hancock Whitney (HWC) Q4 2025 earnings review
Buybacks Surge as Loan Growth Engine Restarts
Hancock Whitney delivered a solid Q4 finish, characterized by a massive acceleration in capital returns and a return to meaningful loan growth. While EPS was flat sequentially at $1.49, the bank aggressively deployed capital, repurchasing ~2.5 million shares (approx. 3% of outstanding) in a single quarter. Loan growth accelerated to 6% annualized, driven by healthcare and equipment finance, validating the 'pivot to growth' narrative management teased earlier in the year. While NIM compressed slightly (-1 bp) and efficiency ticked higher, the 2026 guidance for mid-single-digit loan growth suggests the demand trough is in the rearview mirror.
🐂 Bull Case
Management exhausted the share repurchase authorization, buying back ~2.54 million shares in Q4 alone. A new plan authorizing up to 5% of shares through 2026 signals continued support for the stock.
Despite broader economic jitters, criticized commercial loans decreased to 2.88% (from 3.01%) and nonaccrual loans dropped to 0.45% (from 0.48%). The portfolio is holding up better than peer averages.
🐻 Bear Case
Net Interest Margin dipped 1bp to 3.48% as loan yields fell 10bps, outpacing the drop in funding costs. With the Fed cycle uncertain, asset yield pressure remains a headwind.
While deposits grew 9% annualized, the growth was driven entirely by volatile, seasonal public funds (+15% linked-quarter). Core retail time deposits actually declined.
⚖️ Verdict: 🟢
Bullish. The combination of accelerating loan growth and massive share buybacks outweighs minor margin compression. Credit quality improvements remove the biggest overhang.
Key Themes
Share Repurchase Acceleration
HWC shifted capital return into overdrive. After buying ~660k shares in Q3, they repurchased over 2.5 million shares in Q4. This lowered CET1 by 43bps but demonstrates high conviction in valuation. A new 5% buyback authorization for 2026 ensures this tailwind continues.
Loan Production Revitalized
Accelerating. Loan growth hit 6% linked-quarter annualized, a significant improvement from the contraction seen in early 2025. Drivers include strong healthcare production, increased ICRE activity, and equipment finance. This sets the stage for the mid-single-digit growth guidance for 2026.
Deposit Mix Shift
Stable but mixed quality. Total deposits rose $620M, but the composition is lower quality. Public funds (seasonal/hot money) surged $417M, while stickier retail time deposits fell $90M. Noninterest-bearing DDAs grew slightly (+1%) but largely due to public fund inflows.
Bond Portfolio Restructuring
Management announced the 'completion of a bond portfolio restructuring' coincident with earnings. While details are sparse in the release, this implies a move to trade low-yielding assets for higher current yields, likely creating a one-time capital hit in exchange for future NIM expansion in 2026.
Expense Creep
Decelerating efficiency. Noninterest expense rose 2% QoQ to $217.9M. The efficiency ratio deteriorated to 54.93% from 54.10% in Q3. Higher advertising and data processing costs drove the increase, partially offsetting revenue gains.
Other KPIs
Stable. Down 1 basis point QoQ. Lower loan yields (-10 bps) were the primary drag, partially offset by higher securities yields (+2 bps) and managing liability costs. The ability to defend NIM near 3.50% in a rate-cutting environment is critical.
Stable. Flat vs Q3 2025 and up 6% YoY ($1.40). Growth was driven by share count reduction and lower provision expense, offsetting the slight efficiency drag.
Decelerating. Down 43bps from 14.09% in Q3. This was a deliberate capital consumption event driven by the aggressive share repurchase program.
Guidance
Stable/Accelerating. Maintains the momentum seen in Q4 (+6% annualized). Management expects the current production run-rate to sustain through 2026.
Stable. Conservative outlook relative to loan growth, implying the loan-to-deposit ratio (currently 82.3%) may tick up slightly or remain flat.
Accelerating. New authorization through Dec 2026 replaces the exhausted plan. 5% of float represents roughly 4.1 million shares, indicating the buyback pace may normalize but remain a key TSR driver.
Key Questions
Bond Restructuring Impact
You mentioned a completed bond portfolio restructuring. What was the realized loss associated with this trade, and what is the expected accretion to NIM and EPS in 2026?
NIM Trajectory
Loan yields compressed 10bps this quarter. With the Fed easing cycle potentially continuing, do you see NIM drifting below 3.45%, or will the bond restructuring provide a floor?
Deposit Seasonality vs Core
Q4 deposit growth was heavily reliant on public funds. Excluding seasonal flows, how are core commercial and retail deposit balances trending, and is pricing pressure alleviating?